Frontiers journals are at the top of citation and impact metrics
The rate of dementia is rising sharply.
More than 48 million people around the world are already affected, and this number is expected to double every 20 years, reaching 131 million in 2050. Caring for people with dementia presents profound emotional, physical, and financial challenges to families and societies. There is currently no known prevention, cure, or effective treatment for dementia.
Dementia is a specialty section of Frontiers in Neurology that aims to publish significant clinical, translational, and basic research findings on all of aspects of dementia due to neurodegenerative disease. We welcome papers on cognitive, behavioral, and motor features of dementia. Papers address the broad spectrum of dementia, including but not limited to the model care of people with dementia, caregiver health and wellbeing, concussion and chronic traumatic encephalopathy, molecular insights into pathological prediction and disease mechanism, biomarkers for diagnosis and progression, potential therapeutics and clinical trials, or the relation between inflammation and neurodegeneration. Other important areas will be prevention and healthy aging. Studies that create translational links between basic and clinical research will be particularly valued.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, EMBASE, Science Citation Index Expanded, CLOCKSS
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com